Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 5446 to 5460 of 7685 results

  1. What is the impact and longer-term clinical outcomes of adding procalcitonin testing to standard clinical practice with protocol-driven care in the NHS, to guide the use of antibiotic treatment in children having antibiotics for a suspected or proven infection in an intensive care unit?

    Recommendation ID DG18/2 Question What is the impact and longer-term clinical outcomes of adding procalcitonin testing to standard clinical

    Research recommendation
    Published
    12 January 2016

  2. What is the effectiveness of using defined approaches or decision support toolkits to determine nursing staff requirements and skill mix on acute adult inpatient wards in the UK?

    Recommendation ID SG1/3 Question What is the effectiveness of using defined approaches or decision support toolkits to determine nursing

    Research recommendation
    Published
    9 June 2015

  3. What is the impact and longer-term clinical outcomes of adding procalcitonin testing to standard clinical practice with protocol-driven care in the NHS, to guide the use of antibiotic treatment in people with confirmed or highly suspected sepsis in intensive care units and in people with suspected bacterial infections presenting to the emergency department?

    Recommendation ID DG18/1 Question What is the impact and longer-term clinical outcomes of adding procalcitonin testing to standard clinical

    Research recommendation
    Published
    12 January 2016

  4. Vagus nerve stimulation: What is the effectiveness of vagus nerve stimulation in treating epilepsy (including people with learning disabilities as a subgroup)?

    Recommendation ID NG217/04 Question Vagus nerve stimulation: What is the effectiveness of vagus nerve stimulation in treating epilepsy

    Research recommendation
    Published
    11 May 2022

  5. Intra-arterial therapies to manage delayed cerebral ischaemia: What is the impact of intra-arterial therapies to manage delayed cerebral ischaemia on outcome in people with aneurysmal subarachnoid haemorrhage?

    Recommendation ID NG228/10 Question Intra-arterial therapies to manage delayed cerebral ischaemia: What is the impact of intra-arterial

    Research recommendation
    Published
    12 December 2022

  6. Impact of neonatal infection on the baby's family: What is the impact of neonatal infection on the health-related quality of life of the baby's family?

    Recommendation ID NG195/7 Question Impact of neonatal infection on the baby's family: What is the impact of neonatal infection on the health-related

    Research recommendation
    Published
    6 August 2021

  7. What is the impact of pharmacological interventions for the management of postpartum haemorrhage on breastfeeding and women's and their birth companions' experience and satisfaction in the postnatal period?

    Recommendation ID NG235/4 Question What is the impact of pharmacological interventions for the management of postpartum haemorrhage on

    Research recommendation
    Published
    11 January 2024

  8. Intracranial hypertension: What is the impact of routine monitoring of intracranial hypertension on subsequent management and outcome in people with aneurysmal subarachnoid haemorrhage who are unconscious or ventilated on an intensive care unit?

    Recommendation ID NG228/09 Question Intracranial hypertension: What is the impact of routine monitoring of intracranial hypertension on

    Research recommendation
    Published
    12 December 2022

  9. What is the impact of using the VivaScope 1500 and 3000 imaging systems in the clinical workflow of melanoma and basal cell carcinoma assessment in secondary care in England, particularly on excision rates, diagnostic accuracy, health related quality of life and associated NHS costs?

    Recommendation ID DG19/1 Question What is the impact of using the VivaScope 1500 and 3000 imaging systems in the clinical workflow of melanoma

    Research recommendation
    Published
    12 January 2016

  10. What is the improvement in the cost-effectiveness metrics for statin therapy in reducing CVD that can be obtained when using a complete individual patient-based outcomes meta-analysis data set compared with using published outcomes data?

    Recommendation ID CG181/2 Question What is the improvement in the cost-effectiveness metrics for statin therapy in reducing CVD that can

    Research recommendation
    Published
    9 June 2015

  11. What is the incidence and prevalence of, and what are the demographic trends in, skin cancer in the UK? (Demographic variables might include whether someone is an outdoor or indoor worker, their skin type and socioeconomic status.)

    Recommendation ID PH32/1 Question What is the incidence and prevalence of, and what are the demographic trends in, skin cancer in the UK

    Research recommendation
    Published
    9 June 2015

  12. Antibiotics for suspected early-onset infection: What is the incidence and severity of adverse effects with antibiotics used to prevent or treat early-onset neonatal infection?

    Recommendation ID NG195/13 Question Antibiotics for suspected early-onset infection: What is the incidence and severity of adverse effects

    Research recommendation
    Published
    6 August 2021

  13. Antibiotics for suspected early-onset infection: What is the incidence in England and Wales of resistance to commonly used antibiotics among bacteria that cause early-onset neonatal infection?

    Recommendation ID NG195/11 Question Antibiotics for suspected early-onset infection: What is the incidence in England and Wales of resistance

    Research recommendation
    Published
    6 August 2021

  14. What is the incidence of lentigo maligna diagnosed in England and which different therapies are used to treat lentigo maligna?

    Recommendation ID DG19/5 Question What is the incidence of lentigo maligna diagnosed in England and which different therapies are used

    Research recommendation
    Published
    12 January 2016

  15. Long-term complications of spondyloarthritis:- What is the incidence of long-term complications, in particular osteoporosis, cardiovascular disease (CVD) and metabolic syndrome, in people with spondyloarthritis, and how does this compare with the general population? Are any specific spondyloarthritis features or risk factors associated with the incidence and outcomes of these complications?

    Recommendation ID NG65/2 Question Long-term complications of spondyloarthritis:- What is the incidence of long-term complications, in particular

    Research recommendation
    Published
    4 May 2017